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CASE REPORTS

Use of Triple-Site Ventricular Pacing in a Patient with
Severe Congestive Heart Failure and Atrial Fibrillation
FAIZEL OSMAN, M.D.,* MOHAMED JEILAN, M.B.,† and G. ANDRE NG, PH.D.†
From the *Department of Cardiology, University Hospital Coventry, Coventry, UK; and the †Department of
Cardiology, Glenfield Hospital, University Hospitals of Leicester, Leicester, UK

Cardiac resynchronization therapy (CRT) has become an accepted treatment for selected patients with
drug-resistant heart failure. Data for patients in atrial fibrillation (AF) remains limited but suggests benefit
in these patients too. We report the case of an 82-year-old patient with heart failure, VVIR permanent
pacemaker, and permanent AF who had an upgrade to triple-site CRT implantation with good clinical
response. Triple-site ventricular pacing may enhance the chance of response and LV reverse remodeling
and should be considered in AF patients undergoing CRT implantation. (PACE 2009; 32:673–674)
Cardiac resynchronization therapy, triple-site ventricular pacing
Case Report
An 82-year-old man with previous mitral
valve replacement (bioprosthesis), permanent
atrial fibrillation (AF), and single-chamber VVIR
permanent pacemaker presented with increasing breathlessness. His pacemaker had been implanted in 2004 for bradycardia associated with
AF. On questioning he had New York Heart
Association class IV heart failure symptoms despite optimal medical therapy. On examination he
was in cardiac failure, and resting 12-lead electrocardiogram showed a paced ventricular rhythm
(QRS duration 180 ms) with underlying AF. His
pacing check revealed he was requiring right ventricular pacing 91% of the time. Transthoracic
echocardiography with his intrinsic rhythm (intrinsic QRS duration 150 ms) revealed severe left
ventricular impairment (ejection fraction <30%)
and mild mitral regurgitation. Coronary angiography revealed only mild-to-moderate coronary
artery disease with no revascularization targets.
Given these findings he underwent cardiac
resynchronization therapy (CRT) upgrade. During
implantation coronary venography revealed poor
distal target vessels; however, a small posterolateral branch and anterior branch were noted and
an attempt was made to place two left ventricular (LV) pacing leads. A unipolar Medtronic 4193
(Minneapolis, MN, USA) LV lead was inserted
into a posterolateral branch with excellent pacing/sensing data with a second Medtronic 4193 LV
lead positioned in an anterior branch, again with
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excellent data (Fig. 1). The two LV leads and right
ventricular lead were connected to a Guidant Contak Renewal (Boston Scientific, Natick, MA, USA)
pulse generator with the shortest programmable
AV delay of 10 ms and placed into a prepectoral
pocket. The patient’s symptoms improved almost
immediately and he remains well at follow-up.
CRT has become an accepted treatment for selected patients with drug-resistant heart failure.1
Data for patients in AF remain limited but suggest benefit in these patients too. The recently
published TRIP-HF (Triple Resynchronization in
Paced Heart Failure Patients)2 study compared
triple-site stimulation—two epicardial transvenous leads placed on the anterior and lateral or
posterolateral LV wall and one right ventricular

Figure 1. Left anterior oblique projection showing two
unipolar left ventricular leads placed in the posterolateral and anterior coronary venous system.
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lead with conventional biventricular pacing. The
study enrolled patients with severe heart failure presenting with a slow ventricular rate during AF and showed that compared with dual-site
biventricular pacing, triple-site ventricular stimulation promoted further LV reverse remodeling

as assessed by LV end-systolic and end-diastolic
volumes and ejection fraction, at 3-month followup. Triple-site ventricular pacing may enhance the
chance of response and LV reverse remodeling and
may be considered in AF patients undergoing CRT
implantation.
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